Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance

NCT: NCT07020637 · COMPLETED

NCT IDNCT07020637
StatusCOMPLETED
Start Date2024-10-19
Completion2026-04-30
SponsorUniversity of Nevada, Las Vegas (OTHER)
First posted
Last updated

Brief Summary

This study aims to evaluate the correlation between stroke volume measurements obtained by transthoracic echocardiography and bioreactance-based noninvasive cardiac output monitoring. The primary objective is to assess the level of agreement between these two modalities in critically ill patients.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑